Allied Corp Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities
KELOWNA, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Day: April 24, 2021
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2020
SUZHOU and SHANGHAI, China, April 23, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical...
ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOLANA BEACH, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform...
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq:...
Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market
MALVERN, Pa., April 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing...
Chadwick Boseman Tribute NFT Auction to Benefit the Colon Cancer Foundation
Chadwick Boseman Tribute NFT NFT by artist Andre Oshea in tribute to Chadwick Boseman, raising money for the Colon Cancer...
GENFIT: Publication of the 2020 Universal Registration Document and the 2020 Annual Report on Form 20-F; Annual Shareholders Meeting to take place on June 15, 2021
Lille, France; Cambridge, MA; April 23, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...
ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen Prescription Strength Tablets and Folic Acid Prescription Strength Tablets
FORT LAUDERDALE, Fla., April 23, 2021 (GLOBE NEWSWIRE) -- ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into...
Santhera to Announce 2020 Results on April 29, 2021
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results on Thursday, April 29, 2021, at...
Microbix Receives $4.25 Million Order For Viral Transport Medium
An Initial Order From Government Of Ontario Procurement AuthoritiesMISSISSAUGA, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under...
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young...
Dermatology Experts Present Latest Information at AAD VMX 2021
ROSEMONT, Ill., April 23, 2021 (GLOBE NEWSWIRE) -- The AAD VMX 2021, a virtual meeting experience taking place April 23-25,...
Arcutis Biotherapeutics Showcases New Roflumilast Data in Psoriasis and Seborrheic Dermatitis at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021
Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured in late-breaking oral presentationData demonstrate...
Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential Treatment for Primary Axillary Hyperhidrosis
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful...
Valley Oaks Medical Group: Healthcare Made Affordable for Medicare-Eligible Seniors
LAS VEGAS, NV / ACCESSWIRE / April 23, 2021 / Barriers are affecting senior citizens from getting the help they need...